SCHEMBL7119942

SCHEMBL7119942

CC(C)C(Oc1cccc(C(=N)N)c1)C(=O)Nc1ccc(-c2ccccc2S(N)(=O)=O)cc1

nearest known ligand 0.75

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.75
PRSS1 P07477 5/20 0.75
PLG P00747 1/20 0.64
PROC P04070 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6303269 0.93 F10 (0.67) F10PRSS1PLGPROC
SCHEMBL7600812 0.86 F10 (0.72) F10PRSS1PLGPROC
SCHEMBL7114688 0.86 F10 (0.60) F10PRSS1PLGPROC
SCHEMBL7118516 0.86 F10 (1.00) F10PRSS1PLGPROC
SCHEMBL7597733 0.85 F10 (0.73) F10PRSS1PLGPROC
SCHEMBL7599312 0.84 F10 (0.71) F10PRSS1PLGPROC
SCHEMBL7596363 0.83 F10 (0.70) F10PRSS1PLGPROC
SCHEMBL7122831 0.82 F10 (0.73) F10PRSS1PLGPROC
SCHEMBL7115966 0.81 F10 (0.70) F10PRSS1
SCHEMBL7451044 0.81 F10 (0.70) F10PRSS1PLGPROC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030135055-A1 Aminosulfonylbiphenyl derivatives MERCK PATENT GMBH (DE) 2003-07-17 US claimed
US-20030135055-A1 Aminosulfonylbiphenyl derivatives MERCK PATENT GMBH (DE) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030135055-A1 Aminosulfonylbiphenyl derivatives APOB, F12, SERPINB1 F10 60/4885PRSS1 34/4885PLG 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.